They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration
**Emothion is a trademark of Gnosis SPA
Using the safety and feasibility data from these first-in-human trials demonstrating that intermittent D+Q was well tolerated in 50 subjects (NCT 02874989 and NCT 02848131), combined with the efficacy data in mouse models, we initiated a Phase I study of senolytic therapy in older adults with early-stage symptomatic AD, SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimers Disease, NCT04063124) (107)
We start with the patient, not the protocol every plan is designed around your goals, lifestyle and bloodwork rather than fitted to a fixed package
Our approach at Cymbiotika is rooted in these pillars
Advanced Liposomal Absorption